William Fairey

CIK 1727275 · EVP, Chief Commercial Officer · last filed 2026-06-11

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$248.4K

Companies

6

Total Filings

19

Lifetime Open-Market Net

-$352.3K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
KALV Director $27.00 $0 4 2026-06-11
RNTX Director $0.96 $0 1 2025-07-23
MIRM Director 2,500 $99.34 $248.4K -$155.1K 6 2025-06-13
Rein Therapeutics, Inc. (ALRN) Delisted Director $2.11 $0 3 2024-12-06
MyoKardia, Inc. (MYOK) Delisted See Remarks 8,125 -$197.2K 3 2020-02-19
CCXI Chief Operating Officer $10.22 $0 1 2018-01-05

Recent Filings · Page 2 of 2

19 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2023-11-02 Rein Therapeutics, Inc. (ALRN) Delisted Grant (A) $0 EDGAR
2023-06-14 MIRM Grant (A) $0 EDGAR
2022-06-06 MIRM Grant (A) $0 EDGAR
2021-08-20 MIRM Grant (A) $0 EDGAR
2020-11-19 Mixed −42,199 $0
2020-02-19 MyoKardia, Inc. (MYOK) Delisted Grant (A) $0 EDGAR
2020-02-03 MyoKardia, Inc. (MYOK) Delisted Mixed +5,226 -$197.2K EDGAR
2019-02-05 MyoKardia, Inc. (MYOK) Delisted Grant (A) $0 EDGAR
2018-01-05 CCXI Grant (A) $0 EDGAR
Showing 1119 of 19
Page 2 of 2
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.